Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Brigatinib (BRG) vs Crizotinib (CRZ) in Patients (Pts) With ALK Inhibitor-Naive Advanced ALK plus NSCLC from ALTA-1L
- Authors
- Yang, JCH[Yang, James C. H.]; Kim, HR[Kim, Hye R.]; Ahn, MJ[Ahn, Myung-Ju]; Han, JY[Han, Ji-Youn]; Hochmair, MJ[Hochmair, Maximilian J.]; Lee, KH[Lee, Ki H.]; Delmonte, A[Delmonte, Angelo]; Campelo, MRG[Garcia Campelo, Maria R.]; Kim, DW[Kim, Dong-Wan]; Felip, E[Felip, Enriqueta]; Califano, R[Califano, Raffaele]; Spira, A[Spira, Alexander]; Gettinger, S[Gettinger, Scott]; Tiseo, M[Tiseo, Marcello]; Haney, J[Haney, Jeff]; Kerstein, D[Kerstein, David]; Popat, S[Popat, Sanjay]; Camidge, DR[Camidge, D. R.]
- Issue Date
- Oct-2019
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.30
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 30
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.